Viewing nowCombinationLozazin Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 200708264 · Notified 2007.07.16 · Insurance code 648500610
Treatment of hypertension not controlled with monotherapy
This medication is used for patients with hypertension whose blood pressure is not sufficiently controlled with monotherapy.
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg daily are not recommended. In general, the maximum blood pressure-lowering effect occurs approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the expected effect is not achieved with monotherapy. 1. Replacement therapy: Combination therapy with individually titrated doses of losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Use the usual dose if creatinine clearance is 30 mL/min or higher. Administration to patients with more severe renal impairment is not recommended, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Administration to patients with hepatic impairment requiring dose adjustment is not recommended, because the initial dose of losartan potassium for such patients, 25 mg, cannot be administered using this medicine.
○ Children (under 18 years) Since there is no experience of use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication may cause serious harm to the fetus during pregnancy, and it should not be taken by women who are pregnant or may become pregnant. Patients with allergic reactions to this medication, certain kidney dysfunctions, liver dysfunctions, electrolyte imbalances, and certain genetic diseases should also not take this medication. Patients with excessively low blood pressure or abnormalities in renal blood vessels, liver disease patients, patients with diabetes, etc., should take this medication with caution, and the risk of skin cancer may increase, so skin condition should be regularly monitored. During treatment, regular checks of blood pressure, kidney function, electrolyte levels, etc., should be performed to ensure there are no abnormalities, particularly potassium levels. This medication may interact with other drugs, so if you are taking other medications, you must consult your doctor or pharmacist. Caution is required while driving or operating machinery, as dizziness or drowsiness may occur. In case of overdose, symptoms such as hypotension or cardiac arrhythmias may appear, and immediate medical assistance should be sought. Keep out of reach of children, and store in the original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container to block light. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature.
Yellow oval film-coated tablet
For domestic use: 30 tablets/bottle, 300 tablets/bottle For export: 30 tablets/bottle, 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.